Incidence of esophagitis, peptic ulcers and small intestinal mucosal lesions induced by loxoprofen, etodolac and celecoxib in healthy volunteers: a prospective randomized comparative trial
Latest Information Update: 08 Jan 2013
At a glance
- Drugs Celecoxib (Primary) ; Etodolac (Primary) ; Loxoprofen (Primary) ; Famotidine
- Indications Musculoskeletal disorders; NSAID-induced gastric damage; NSAID-induced gastrointestinal damage; Pain; Rheumatic disorders
- Focus Adverse reactions; Therapeutic Use
- 08 Jan 2013 New trial record